Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.52 |
| ▸ | FYN | P06241 | 11/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | BRD4 | O60885 | 1/20 | 0.41 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | GFER | P55789 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21420016 | 0.84 | ALDH1A1 (0.48) | ALDH1A1HSD17B10FYNNOTUMTSHR | |
| Cyclohexane SCHEMBL29105459 | 0.83 | FYN (0.44) | ALDH1A1HSD17B10FYNNOTUMTSHR | |
| SCHEMBL6572818 | 0.82 | FYN (0.46) | ALDH1A1HSD17B10FYNNOTUMTSHR | |
| SCHEMBL12460936 | 0.81 | ALDH1A1 (0.57) | ALDH1A1HSD17B10FYNL3MBTL1BRD4 | |
| SCHEMBL3785053 | 0.80 | ALDH1A1 (0.45) | ALDH1A1HSD17B10FYNL3MBTL1KDM4E | |
| SCHEMBL5162068 | 0.80 | ALDH1A1 (0.71) | ALDH1A1HSD17B10L3MBTL1TSHRKDM4E | |
| SCHEMBL1133154 | 0.79 | HTR7 (0.54) | ALDH1A1HSD17B10FYNNOTUMTSHR | |
| SCHEMBL3793335 | 0.79 | ALDH1A1 (0.58) | ALDH1A1HSD17B10L3MBTL1TSHRKDM4E | |
| SCHEMBL26128565 | 0.78 | ALDH1A1 (0.52) | ALDH1A1HSD17B10FYNNOTUMTSHR | |
| SCHEMBL30602821 | 0.77 | ALDH1A1 (0.58) | ALDH1A1HSD17B10FYNNOTUMTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100087680-A1 | METHOD FOR PRODUCING BIARYL COMPOUND | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 2010-04-08 | — | — | US | disclosed |
| EP-1914221-A1 | PROCESS FOR PRODUCING BIARYL COMPOUND | Sumitomo Chemical Company, Limited (JP) | 2008-04-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100087680-A1 | METHOD FOR PRODUCING BIARYL COMPOUND | NISCH, BLVRB, BBOX1 | ALDH1A1 4339/4885HSD17B10 1100/4885FYN 390/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.